Self-assembly-integrated tumor targeting and electron transfer programming towards boosting tumor type I photodynamic therapy

Wenlong Chen,Zehui Wang,Gaobo Hong,Jianjun Du,Fengling Song,Xiaojun Peng

DOI: https://doi.org/10.1039/d4sc03008g

IF: 8.4

2024-06-20

Chemical Science

Abstract:Type I photodynamic therapy (PDT) is attracting increasing interest as an effective solution to the poor prognosis of patients with hypoxic tumors. The development of functional type I photosensitizers is limited by a lack of feasible strategies to systematically modulate electron transfer (ET) in photosensitization. Herein, we present an easily accessible approach for the preparation of nanophotosensitizers with self-assembly-integrated tumor-targeting and ET programming towards boosting tumor type I PDT. Specifically, a dual functional amphiphile PS-02 was designed with a ligand ( 6-NS ) that had the ability to not only target tumor cell marker carbonic anhydrase IX ( CAIX ) but also regulate the ET process for type I PDT. The amphiphile PS-02 tended to self-assemble into PS-02 nanoparticles (NPs), which exhibited a local "ET-cage effect" due to the electron-deficient nature of 6-NS . It is noteworthy that when PS-02 NPs selectively targeted the tumor cells, the CAIX binding enabled the uncaging of the inhibited ET process owing to the electron-rich characteristic of CAIX . Therefore, PS-02 NPs integrated tumor targeting and CAIX activation towards boosting type I PDT. As a proof of concept, the improved PDT performance of PS-02 NPs was demonstrated with tumor cells under hypoxic conditions and solid tumor tissue in mouse in vivo experiments. This work provides a practical paradigm to develop versatile type I PDT nano-photosensitizers by simply manipulating ET and easy self-assembling.

chemistry, multidisciplinary

What problem does this paper attempt to address?

This paper aims to solve the problem of the poor effect of tumor photodynamic therapy (PDT) in hypoxic tumors. Specifically, the paper proposes a new strategy to enhance the effect of tumor type I photodynamic therapy through self - assembly and electron - transfer programming. The main objectives include:

1. **Develop functional type I photosensitizers**: Since most photosensitizers proven effective in clinical trials rely on the presence of oxygen (i.e., type II photodynamic therapy), this limits their efficacy in hypoxic tumors. Therefore, it is particularly important to develop functional type I photosensitizers that are not dependent on oxygen.

2. **Improve tumor - targeting ability**: By designing photosensitizers with the ability to target the tumor marker carbonic anhydrase IX (CAIX), selective recognition and enrichment of tumor cells can be achieved, thereby reducing the toxic side effects on normal tissues.

3. **Optimize the electron - transfer process**: By introducing electron - donor groups (such as piperazine) and electron - acceptor groups (such as 6 - NS), the electron - transfer process of photosensitizers is regulated to enhance the effect of type I photodynamic therapy.

4. **Verify in - vivo and in - vitro effects**: Through in - vitro experiments and in - vivo experiments in mice, the photodynamic therapy effect of the designed nanophotosensitizer PS - 02 NPs under hypoxic conditions is verified.

The paper achieves the above objectives by designing and synthesizing two amphiphilic molecules, PS - 01 and PS - 02, and self - assembling them into nanoparticles. In particular, PS - 02 NPs can uncage the electron - transfer process in tumor cells by targeting CAIX, thereby significantly enhancing the effect of type I photodynamic therapy. These results provide new ideas and methods for the development of multifunctional nanophotosensitizers.